IHL Chart Technicals, page-171

Yes EB, but it looks like the market doesn't give a rat's ass about anything else not related to MedCann. Which is fair, but something I've noticed with IHL so far. Shame many are writing off the dental biz but that's how it is, looking forward to the 4C and hopefully the last CR behind us with increased sales, international expansion, CBD products that will be sold when trials work, decreased costs 800K/Year with Shenzen manufacturing etc.... Currently cashed up and with oppies all expiring 2020 its make or break.